期刊文献+

深圳市健康人群水痘-带状疱疹病毒血清流行病学调查 被引量:18

Seroepidemiological survey of prevalence of varicella-zoster virus in healthy population in Shenzhen City
下载PDF
导出
摘要 目的 了解深圳市人群水痘-带状疱疹病毒(VZV)的流行现状,为制定水痘防制措施提供依据。方法采用酶联免疫吸附试验(ELISA)对深圳市348名健康人群血清血标本进行抗-VZV IgG抗体检测。结果348份血清标本中,抗-VZV流行率为61.49%。1-5岁、6-10岁、11-15岁、16-20岁、21-30岁、31-40岁年龄别流行率分别11.36%,43.59%,70.83%,82.28%,93.18%,94.00%。水痘流行率以1-5岁最低,仅为11.36%,以后随年龄增长而升高。女性高于男性并有统计学意义(x^2=5.314,P〈0.05)。结论水痘病毒在人群中流行率很高,学龄前儿童为水痘的高危人群,托幼机构存在水痘爆发隐患,建议学龄前儿童普种水痘疫苗。 Objective To understand the prevalent status of varicella - zoster virus in the population of Shenzhen City and provide theoretic basis for the prevention of Varicella- zoster. Methods Serum antibody to varicella - zoster virus were detected in 348 samples by using ELISA. Results Age - specific prevalence rate of six age groups of 1 - 5,6 - 10,11 - 15,16 - 20,21 - 30 and 31 - 40 years were 11.36%, 43.59%, 70.83%, 82.28% ,93.18% and 94.00%, respectively. Sere - prevalence rate of 1- 5 age group was the lowest,it rose fast with age. The prevalence rate of varicella - zoster virus was higher in female (67.65 % ) than in male (55.62%). Conclusion The prevalence rate of varicella - zoster virus in popultion of Shenzhen City was high. Preschool children are the high - risk population. There is potential outbreak of varicella - zoster and all children in nuseries and kindergartens be immunized with varicella vaccine.
作者 王雅妮
出处 《中国热带医学》 CAS 2006年第7期1166-1167,共2页 China Tropical Medicine
关键词 水痘-带状疱疹病毒(VZV) 流行率 水痘疫苗 Varicella - zoster Virus Sere - prevalence rate Vaccine
  • 相关文献

参考文献3

  • 1刘湘云.儿童保健学[M].南京:江苏科学技术出版社,1990,253~254.
  • 2曹惠霖,杜军,贾志远,詹美云,王稳,刘丹,丁丽新,董振英,王伟,梁建华,袁国娟,李燕婷,铁映臻,李志秀.我国部分地区人群中水痘-带状疱疹病毒流行率[J].中国计划免疫,1998,4(1):38-40. 被引量:33
  • 3孙海燕.人群中水痘—带状疱疹病毒流行率及疫苗免疫效果[J].中华流行病学杂志,2001,22(1):62-62.

二级参考文献10

  • 1曾毅.水痘-带状疱疹病毒感染.见黄祯祥主编:医学病毒学基础及实验技术,1990,824-829.
  • 2侯云德.疱疹病毒科.分子病毒学.北京:学苑出版社,1990,114—142.
  • 3Jackson M,et al.Complications of varicella requiring hospitalization in previously bealthy children.Pediatr infect Dis J,1992,11:441.
  • 4Preblod S R.Varicella:Complications and costs.Pediatrics,1986,78:728.
  • 5Committee on Infectious Diseases.Recommendations for the use of live attenuated varicella vaccine.Pediatrics 1995,95(5):791.
  • 6Takahashi M.et al:Live attenuated varicella vaccine used to prevent the spread of varicella in hospital.Lancet 1974.2,1288-1290.
  • 7Plotkin SA,et al.Varicella Vaccine.Pediatrics,1996,97(2):251-253.
  • 8Barzaga N, et al. Proceedings to 4th WPCCID, Suppletion to JAMA Southeast Asia, 1994,633-639.
  • 9Ooi PL, et al.Prevalence of varicella-zoster virus infection on Singapore. SEA J TROP Med Pub Health, 1992,167:195.
  • 10Hossain A.Herpes Simplex virus I (HSU-1) and Varicella-zoster virus(VZV) infections in sandi Arabia.J Trop Pediatrics,1989,35:171.

共引文献34

同被引文献127

引证文献18

二级引证文献164

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部